CCR1 Chemokine Receptor Antagonist
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1201-1208
Author(s):
Toshihiko Saeki and Akira Naya
The Neuropeptides VIP / PACAP and T Cells: Inhibitors or Activators?
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
997-1004
Author(s):
Doina Ganea and Mario Delgado
Vitamin D Receptor as a Drug Discovery Target
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
193-204
Author(s):
Karen V. Pinette, Ying K. Yee, Bernard Y. Amegadzie and Sunil Nagpal
Cytokine Gene Polymorphism in Heart Transplantation: A Review
Journal:
Current Genomics
Volume:
4
Page:
205-215
Author(s):
F. J. Bijlsma, A. H. Bruggink, F. H.J. Gmelig-Meyling and R.A. de Weger
Potential Use of Drugs that Target Neural-Immune Pathways in the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
2
Page:
1-30
Author(s):
D. Lorton, C. Lubahn and D. L. Bellinger
The Study of HLA Class II and Autoimmune Diabetes
Journal:
Current Molecular Medicine
Volume:
3
Page:
1-15
Author(s):
F. Susan Wong and Li Wen
Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
83-94
Author(s):
Ciriaco A. Piccirillo and Gerald J. Prud'homme
Natural Killer T Cells as Targets for Therapeutic Intervention in Autoimmune Diseases
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
201-220
Author(s):
M. T. Wilson and L. Van. Kaer
Dendritic Cell Homeostasis in the Regulation of Self-Reactivity
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
221-231
Author(s):
Burkhard Ludewig, Philippe Krebs, Tobias Junt and Gennady Bocharov
Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
245-256
Author(s):
Orhan Aktas and Frauke Zipp